Role of Podocyte AMP Kinase

다국어 초록 (Multilingual Abstract)

AMP-activated protein kinase (AMPK), as a sensor of cellular energy status, has been known to play an important role in the pathophysiology of diabetes and its complications. As AMPK is also expressed in podocytes, it is possible that podocyte AMPK would be an important contributing factor in the development of proteinuria. In recent years, although interest regarding AMPK in the kidney has intensified, the studies on the role of AMPK in podocytes are limited. In this review, I will discuss the roles of AMPK in podocytes, which may involve in the development of podocyte dysfunction and proteinuria, and the possibility of AMPK-modulating drugs in the prevention and treatment of podocytopathy.

참고문헌 (Reference)

1 Tryggvason K, "Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm" 10 : 2440-2445, 1999

2 Huber TB, "The slit diaphragm: a signaling platform to regulate podocyte function" 14 : 211-216, 2005

3 Asanuma K, "The role of podocytes in glomerular pathobiology" 7 : 255-259, 2003

4 Reiser J, "The glomerular slit diaphragm is a modified adherens junction" 11 : 1-8, 2000

5 Hardie DG, "The AMP-activated protein kinase-fuel gauge of the mammalian cell" 246 : 259-273, 1997

6 Hardie DG, "The AMP-activated protein kinase pathway - new players upstream and downstream" 117 : 5479-5487, 2004

7 Inoki K, "TSC2 mediates cellular energy response to control cell growth and survival" 115 : 577-590, 2003

8 Carrera AC, "TOR signaling in mammals" 117 : 4615-4616, 2004

9 Hallows KR, "Role of the energy sensor AMP-activated protein kinase in renal physiology and disease" 298 : F1067-F1077, 2010

10 Zhou G, "Role of AMP-activated protein kinase in mechanism of metformin" 108 : 1167-1174, 2001

11 Fraser S, "Regulation of the energy sensor AMP-activated protein kinase in the kidney by dietary salt intake and osmolality" 288 : F578-F586, 2005

12 Mundel P, "Podocyte biology and response to injury" 13 : 3005-3015, 2002

13 Giannini S, "Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity" 27 : 982-991, 2004

14 Ha TS, "Pathophysiology of proteinuria" 47 (47): 877-885, 2004

15 D’Amico G, "Pathophysiology of proteinuria" 63 : 809-825, 2003

16 Spiegelman BM, "PPAR-gamma: adipogenic regulator and thiazolidinedione receptor" 47 : 507-514, 1998

17 Moller DE, "New drug targets for type 2 diabetes and the metabolic syndrome" 414 : 821-827, 2001

18 Cusi K, "Metformin: a review of its metabolic effects" 6 : 89-131, 1998

19 Piwkowska A, "Metformin induces suppression of NAD(P)H oxidase activity in podocytes" 393 : 268-273, 2010

20 Musi N, "Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes" 51 : 2074-2081, 2002

21 Stapleton D, "Mammalian AMP-activated protein kinase subfamily" 271 : 611-614, 1996

22 Buhl ES, "Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome" 51 : 2199-2206, 2002

23 Vincent MF, "Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes" 40 : 1259-1266, 1991

24 Wang W, "Increased AMP: ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function" 278 : 27016-27023, 2003

25 Guo Z, "Effect of N-acetylcysteine on plasma adiponectin and renal adiponectin receptors in streptozotocin-induced diabetic rats" 558 : 208-213, 2007

26 Kerjaschki D, "Dysfunctions of cell biological mechanisms of visceral epithelial cell (podocytes) in glomerular diseases" 45 : 300-303, 1994

27 Oh J, "Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome" 19 : 130-137, 2004

28 Fogarty S, "Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer" 1804 : 581-591, 2010

29 Pavenstädt H, "Cell biology of the glomerular podocyte" 83 : 253-307, 2003

30 Kerjaschki D, "Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis" 108 : 1583-1587, 2001

31 Cammisotto PG, "Adiponectin stimulates phosphorylation of AMP-activated protein kinase a in renal glomeruli" 39 : 579-584, 2008

32 Sharma K, "Adiponectin regulates albuminuria and podocyte function in mice" 118 : 1645-1656, 2008

33 Fisher JS, "Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin" 282 : E18-E23, 2002

34 Steinberg GR, "AMPK in health and disease" 89 : 1025-1078, 2009

35 Wong AK, "AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease" 116 (116): 607-620, 2009

36 Eid AA, "AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes" 285 : 37503-37512, 2010

37 Merrill GF, "AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle" 273 : E1107-E1112, 1997

38 Lee MJ, "A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy" 292 : F617-F627, 2007